AdaptDx is designed to be an easy to use macular degeneration diagnostic tool.
Investors contributing to MacuLogix’s Series A funding include Ben Franklin Technology Partners of Central and Northern Pennsylvania, Berwind Private Equity, Roche Venture Fund and Life Sciences Greenhouse of Central Pennsylvania.
More Articles on Ophthalmology:
Flaum Eye Institute Recruits Dr. Harold Ross
MCRHS Eye Care Welcomes Dr. Elizabeth Garland
AAO Survey Finds US Ophthalmologists Foresee Negative Consequences of Medicare Cuts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
